Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction
Gender has a significant impact on IPF outcomes, with women demonstrating better survival and tolerance to long-term therapy. In contrast, reducing antifibrotic treatment does not appear to significantly affect survival outcomes. These findings underscore the need for future research on gender-specific management approaches.
Authors
- Maria Pia Foschino Barbaro (ORCID: https://orcid.org/0000-0001-9939-2697)
- Dalila Pescatore
- Donato Lacedonia (ORCID: https://orcid.org/0000-0003-0429-7967)
- Giulia Scioscia (ORCID: https://orcid.org/0000-0002-2667-077X)
- Cosimo Carlo De Pace (ORCID: https://orcid.org/0000-0001-9777-5598)
- Giulia Maria Stella (ORCID: https://orcid.org/0000-0003-0929-4394)
- Pasquale Tondo (ORCID: https://orcid.org/0000-0002-1202-8567)
- Federica Maci (ORCID: https://orcid.org/0000-0002-6773-5795)
- Fabiola Murgolo
Institutions
- University of Foggia (IT)
- University of Pavia (IT)
- Hospital Madre Teresa (BR)
- Ospedale A. Perrino (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Life
- Published
- 2025-01-16
- DOI
- https://doi.org/10.3390/life15010106
- Citations
- 5
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 7.59